Abstract
The incidence of focal liver lesions (either benign or malignant) has increased drastically the last decades. Treatment possibilities have extended significantly due to improved chemotherapeutic agents, extended eligibility criteria for partial liver resection, the introduction of radiofrequency ablation (RFA) and the development of yttrium radio-embolization. Patients with focal liver lesions
... read more